Oil executive Harold Hamm, who made billions tapping the vast Bakken oil field in North Dakota before other companies saw the potential, sounded a pessimistic tone about whether the industry will develop California’s Monterey Shale formation, which is estimated to have possibly five times more oil.
“It’s just been tough to break the code on how to get that,” said Hamm, founder and CEO of Continental Resources, an independent oil company with the largest footprint in the Bakken oil fields in Western North Dakota. “Everybody thought they could and it hasn’t worked out.”
He added that the field, which is located in the San Joaquin Valley in central California, has not yet matured to a form that companies could develop with today’s technologies.
Speaking at a dinner Wednesday night in Washington with media reporters and other independent-petroleum executives, Hamm said his company had considered pursuing the Monterey formation.
“We went there and thought it might have a lot of potential,” Hamm said. “I’d be out there, but I just can’t do anything different than some of the people who have already been there and made that attempt.”
The oil industry’s potential pursuit of the Monterey shale formation has triggered an intense debate over hydraulic fracturing, or fracking, in California, a drilling technique that’s helped unlock vast reserves of oil and natural gas around the country, including in North Dakota. But it’s controversial for the environmental risks associated with it, including water contamination.
Last month, California’s Democratic Gov. Jerry Brown passed a law regulating fracking.
Called a “pioneer” by Interior Secretary Sally Jewell this summer for his early insight into the oil industry’s potential in North Dakota, Hamm’s glum outlook for the Monterey doesn’t bode well for producers looking to tap into it.
“I don’t see — ” Hamm stopped mid-sentence and recast what he said: “It’s yet to be seen”¦It might have a lot of potential, but there are reasons why it’s not being produced.”
- 1 The Story of 2016: Republicans Feeling “Betrayed” by Their Leaders
- 2 The 14 House Primaries to Watch Tuesday
- 3 After Trump, GOP Foreign Policy Faces an Uncertain Future
- 4 Climate Stances Put Pressure on Major Trade Groups
- 5 Smart Ideas: Oil Pipelines vs. Oil Trains, and the Next Generation of Biological Threats
What We're Following See More »
Sigmar Gabriel, the German economic minister, said there's no chance of the Transatlantic Trade and Investment Partnership being agreed upon before the U.S. elections this fall. Gabriel said the United States "had effectively ended talks" on the free trade deal with the European Union "because Washington had not wanted to compromise with its European counterparts."
In a new Monmouth University poll, 46% of likely voters support Clinton and 39% back Trump, with 7% supporting Libertarian Gary Johnson, and 2% backing Jill Stein of the Green Party. That's down from a poll taken right after the Democratic convention, in which Clinton led by 13 points.
“Hillary Clinton’s advisers are talking to Donald J. Trump’s ghostwriter of The Art of the Deal, seeking insights about Mr. Trump’s deepest insecurities as they devise strategies to needle and undermine him in four weeks at the first presidential debate, the most anticipated in a generation. ... Her team is also getting advice from psychology experts to help create a personality profile of Mr. Trump to gauge how he may respond to attacks and deal with a woman as his sole adversary on the debate stage.”
"Humanity’s impact on the Earth is now so profound that a new geological epoch—the Anthropocene—needs to be declared," according to a panel of scientists. "The new epoch should begin about 1950, the experts said, and was likely to be defined by the radioactive elements dispersed across the planet by nuclear bomb tests, although an array of other signals, including plastic pollution, soot from power stations, concrete, and even the bones left by the global proliferation of the domestic chicken."
The House Committee on Oversight and Government Reform has requested documents from the CEO of Mylan, "the pharmaceutical company under fire after raising the price of EpiPens more than 400 percent since 2007." Meanwhile, top members of the Energy and Commerce Committee are pressing the FDA on the lack of generic competition for EpiPens.